I. Introduction
Cholesterol is a lipid, waxy steroid [1] found in the cell membranes and transported in the blood plasma of all animals. It is an essential component of mammalian cell membranes where it is required to establish proper membrane permeability and fluidity [2] . Cholesterol is the principal sterol synthesized by animals, but small quantities are synthesized in other eukaryotes, such as plants and fungi. It act as the precursor of steroid hormones, bile salts and vitamin D [3] . There are two types of cholesterol HDL and LDL. High density lipoprotein, also known as HDL, is considered the "good" cholesterol. HDL is produced by the liver to carry cholesterol and other lipids (fats) from tissues and organs back to the liver for recycling or degradation. High levels of HDL are a good indicator of a healthy heart low density lipoproteins, or VLDL, are lipoproteins that carry cholesterol from the liver to organs and tissues in the body. They are formed by a combination of cholesterol and triglycerides. VLDLs are heavier than low density lipoproteins, and are also associated with atherosclerosis and heart disease. In human, about 20-25% of total daily cholesterol production occurs in the liver; other sites of cholesterol biosynthesis [4] 1.1 Scheme1: Cholesterol biosynthesis pathway
1.1

Inhibition of cholesterol synthesis:
Biosynthesis of cholesterol can be controlled by inhibiting the activity of enzymes which are involved in the biosynthetic pathway such as HMG Co. A synthase, HMG Co. A reductase, lanosterol synthase etc. Statins (vastatins, pravastatin, simvastatin ,lovastatin etc.,) which are a class of anticholesterol drugs found to be very effective inhibitors of HMG Co.A reductase (Alberts et al.,1980 . Plants sterols show a wide structural variety and significant structural differences from those of animals. The difference in the biosynthesis of sterols between plants and animals begin at the step of cyclization of 2,3-oxido squalene to lanosterol in animals and to cyclo artenol in plants,in the presence of the enzyme lanosterol synthase.
This enzyme majorly related to fluidity and ion permeability. The study of molecular evolution and phylogenitic utility for the lanosterol synthase gene could contribute to the elucidation of evolutionary histories related to lineages of animals and fungi. Although molecular phylogenitics using DNA sequences have solved many controversial systematic problems.
With 5 protein sequences of lanosterol synthase which are included in animals and fungi, 200 homologous sequences were extracted from the UniProt database. The exclusion of paralogous sequences from the dataset composed of 200 homologs, 5 reference sequences, and an out group finally generated a protein alignment of 25 lanosterol synthase and one cycloartenol synthase with the length of 679 amino-acid residues. From the alignment and its codon-based mRNA aligned dataset, the following major results were derived: 1) All phylogenetic trees supported the bifurcation of animals and fungi.
2) The maximum-likelihood parameter estimates of various evolutionary models indicated that most regions of lanosterol synthase have evolved under purifying selection.
3) The gene encoding lanosterol synthase provided the most sufficient phylogenetic information in comparison to the gene encoding the second largest subunit of RNA polymerase II (RPB2) and the small subunit of ribosomal DNA (rDNA-18S). 4) The lanosterol synthase gene and rDNA-18S were highly compatible to each other with strong congruence.
Lanosterol synthase plays central role in cholesterol and sterols biosynthesis, there is a great interest in the identification of drugs that target this enzyme for anticholesteramic purpose.Histone deacetylase 3[HDAC3] repress transcription from the synthesis promoted. The human lanosterol synthase, gene encodes a 732 aminoacid protein with a predicted molecular mass of 83kPA.In human OSC,There is already five natural.ligands present.They are R71A1733,BOGA1734,C14A1735,BOGA1736,BOGA1737.Two crystal structure of human OSC have been reported.A large active site cavity is located in the centre of the molecule between the two domains.
Figure1:Retrieval of structure of human lanosterol synthase from-protein data bank[7]
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II. Computational Details
On the basis of this active site [7] and pharmacophore prediction, we predicted, which ligand bind to the corresponding active site. This process is known as docking. By knowing the structure of ligand in the active site, by using virtul screen we can produce number of derivatives of that ligand. From this process we got an optimized ligand. In silico research in medicine is thought to have the potential to speed the rate of discovery while reducing the need for expensive lab work and clinical trials. One way to achieve this is by producing and screening drug candidates more effectively. In 2010, for example, using the protein docking algorithm EADock (Protein-ligand docking), researchers found potential inhibitors to an enzyme associated with cancer activity in silico [8] .
ZINC DATA BASE was used for making drug derivatives or ligand derivatives. SCHRODINGER GLIDE-9.0 was used for molecular docking. Through molecular docking we tried to predict the structure of the intermolecular complex formed between two or more constituent molecules. It was also used to predict the binding orientation of small drug candidate with their protein target. [9] 
ADMET-prediction [10]
 ADMET calculation was performed using Qik prop to predict the toxicity and side effect of the ligand.  Qik prop predict the physically significant descriptors and pharmaceutically relevant properties for organic structures.  Provides ranges for comparing the particular molecule's properties with those of 95% of known drugs. [11] 
QSAR ANALYSIS
It was done in order to correlate the molecular descriptors [physicochemical properties] with the biological activity, i.e, the docking score by using fast statistics. Using Fast statistics, regression analysis was done and the value coefficient of determination [R squared].
III.
Result And Disscussion The output from in silico development method has been shown in Table[a] and [b] .The value of R squared was found to be 0.1474. R Squared has been used in the context of statistical models, whose main purpose is the prediction of future out comes on the basis of other related information. The normal range of R squared is in the between 1 and 0.
Multiple linear Regression analysis, docking score versus #rotor?(no. of non-trivial, non-hindered rotatable bonds),CNS(predicted central nervous system activity on a -2(inactive) to +2(active)) ,mol MW(molecular weight of the molecule),dipole(computed dipole moment of the molecule),SASA(total solvent accessible surface area in square angstroms using a probe with a1. 
IV. Conclusion
Atherosclerosis is a complex chronic disease characterized by the accumulation of lipids within the arterial walls that eventually go on to from plaques. One well known risk factor in humans in hypercholesterolemia. That is elevated total cholesterol [TC] and [LDL-C]. Statin or HMG CO-A reductase inhibitors are a class of drugs include Pravastin, vastatin, imvastin, lovastatin, fluvastatin, atrovastin etc,that up regulates LDL receptor activity and as a result decrease the plasma cholesterol concentration. Though they are widely used continuous usage of the drugs may causes many serious side effects such as neuropathy, liver damage, kidney failure etc
In the present study [12] large number of ligand were screened to predict their binding affinity with the target Lanosterol Synthase .Some zinc compound like Zinc08442161, Zinc 08442201, Zinc08442127, Zinc019989790, Zinc08442201 and Zinc08442200 gave comparatively high docking score corresponding -11.273,-10.897,-10.407,-10.450 and -10.278 respectively. And their binding affinity can be improved by the ligand optimization that may help in the future development of drug candidate with fewer side effects.
